IL27 and prostate neoplasm: We chose sonodelivery because we have recently utilized this strategy to achieve partial antitumoral responses for IL-27 [1,7], whereas intratumoral rIL-18 has yielded partial antitumor responses when administered directly to prostate tumors [9].